Low CTLA-4 expression in CD4 + helper T-cells in patients with fulminant type 1 diabetes

Immunology Letters

Volumn 139, Issue 1-2, 2011, Pages 80-86

  Haseda, Fumitaka ^a   Imagawa, Akihisa ^a,b   Murase Mishiba, Yuko ^a   Sano, Hiroyuki ^a   Hirano Kuwata, Suzue ^a   Ueda, Hironori ^b   Terasaki, Jungo ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

CD4 +; CTLA 4; Flow cytometry; FOXP3; Fulminant type 1 diabetes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENETIC POLYMORPHISM; HELPER CELL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ADULT; AGED; ANTIGENS, CD; CELL PROLIFERATION; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 79960699580     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.05.003     Document Type: Article

References (22)

1. Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies Osaka IDDM Study Group. N Engl J Med 2000, 342:301-307.
2. Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T., et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 2003, 26:2345-2352.
3. Hanafusa T., Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 2007, 3:36-45.
4. Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T., et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 2005, 48:294-300. [Erratum in: Diabetologia, 51, 524-526, 2008].
5. Tanaka S., Kobayashi T., Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med 2000, 342:1835-1837.
6. Shibasaki S., Imagawa A., Tauriainen S., Iino M., Oikarinen M., Abiru H., et al. Expression of toll-like receptors in pancreas of recent-onset fulminant type 1 diabetes. Endocrinol J 2010, 57:211-219.
7. Kotani R., Nagata M., Imagawa A., Moriyama H., Yasuda H., Miyagawa J., et al. T lymphocyte response against pancreatic beta cell antigens in fulminant type 1 diabetes. Diabetologia 2004, 47:1285-1291.
8. Linsley P.S., Bradshaw J., Greene J., Peach R., Bennett K.L., Mittler R.S. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996, 4:535-543.
9. Egen J.G., Allison J.P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002, 16:23-35.
10. Rudd C.E. The reverse stop-signal model for CTLA4 function. Nat Rev Immunol 2008, 8:153-160.
11. Ise W., Kohyama M., Nutsch K.M., Lee H.M., Suri A., Unanue E.R., et al. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanism. Nat Immunol 2010, 11:129-135.
12. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27.
13. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
14. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
15. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
16. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322:271-275.
17. Seino Y., Nanjo K., Tajima N., Kadowaki T., Kashiwagi A., Akai E., et al. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus; Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010, 1:212-228.
18. Ueda H., Howson J.M.M., Esposito L., Heward J., Snook J., Chmberlain G., et al. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
19. Kawasaki E., Imagawa A., Makino H., Uga M., Abiru N., Hanafusa T., et al. Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 2008, 31:1608-1610.
20. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharp A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fetal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunology 1995, 3:541-547.
21. Schmidt E.M., Wang C.J., Ryan G.A., Clough L.E., Qureshi O.S., Goodall M., et al. Ctla-4 controls regulatory T cell peripheral homeostasis and required for suppression of pancreatic islet autoimmunity. J Immunol 2009, 182:274-282.
22. Flores-Borja F., Jury E.C., Mauri C., Ehrenstein M.R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A 2008, 105:19396-21940.